WT1 187-195 (HLA-A*02:01)
( SLGEQQYSV )
SLGEQQYSV is a linear peptidic epitope (epitope ID59130) studied as part of Wilms tumor protein from Homo sapiens (human), tested in T cell assays
Sequence: | SLGEQQYSV | |
Gene: | WT1 | |
Delivery: | 2-3 days | |
C-Terminus: | OH | |
N-Terminus: | H | |
Amount: | 1 mg | |
Counter Ion: | TFA | |
Protein: | Wilms-Tumor-Protein | |
Species: | Human | |
Allele: | HLA-A*02:01 | |
Application : | Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry | |
Indication : | AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 | |
Purity : | 95% HPLC-MS |
Protocols and Tips
Data sheets
Safety data sheet poly peptides:
Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
€60.40*
Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Product number:
EP11468_1